Department of Anesthesiology and Pain Medicine and Anesthesia
Seoul, 120-752, South Korea
NCT Number: NCT02720549
Ischemic reperfusion injury of cardiopulmonary bypass and postoperative renal dysfunction is a common problem which influence poor outcome in subjects undergoing valvular heart surgery. The incidence of postoperative renal dysfunction was reported as high as 7~8% in heart surgery using bypass, and is thought to be caused by ischemia/reperfusion injury. Remote ischemic postconditioning was also reported to be protective for ischemic/reperfusion injury in previous animal studies and stoke patients. Therefore, the investigators are trying to evaluate the clinical effect of remote ischemic postconditioning on postoperative renal dysfunction in subjects undergoing valvular heart surgery with bypass.
Looking for future studies?
Notify Me19 year–80 year
All sexes
Interventional
Not applicable
Seoul, 120-752, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Remote ischemic postconditioning post group will take a remote ischemic postconditioning with tourniquet in their lower extremity under thigh. The conditioning is 5 minutes of inflation, and 5 minutes of deflation, repeated 3 cycles.
valvular surgery with bypass
Time frame: 5 days
Yonsei University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07489313
Aortic or Mitral Valve Replacement, Valvular Heart Disease Patients
View Trial DetailsNCT07456085
Cardiovascular Diseases, Embolism and Thrombosis
Rawalpindi, Punjab Province, Pakistan
View Trial DetailsNCT07450287
Adenocarcinoma, Carcinoid Heart Disease
Warsaw, Poland
View Trial DetailsNCT07023510
Valvular Heart Disease Patients
Taipei, Taiwan
View Trial Details